Table 1 Baseline characteristics and laboratory values of the study groups according to TIMI thrombus grade

Age (year)

62 ± 18

61 ± 18

63 ± 17

0.035*

Male, n (%)

462 (74.3)

245 (72.2)

217 (76.6)

0.231

LVEF, %

50 ± 8.5

50 ± 7

50 ± 5

0.009*

Diabetes mellitus, n (%)

286 (46)

140 (41)

146 (52)

0.010*

Hypertension, n (%)

374 (60)

196 (58)

178 (63)

0.218

Hyperlipidemia, n (%)

260 (42)

134 (40)

126 (45)

0.208

Previous stroke, n (%)

38 (6)

22 (7)

16 (6)

0.665

Congestive heart failure

114 (18)

52 (15)

62 (22)

0.038*

Previous history of CAD

214 (34)

125 (37)

89 (31)

0.175

Glucose, mg/dl

119 ± 82

111 ± 62

129 ± 95

< 0.001*

Creatinine, mg/dl

0.9 ± 0.2

0.8 ± 0.2

0.9 ± 0.2

0.035*

LDL-C, mg/dl

110 ± 52

107 ± 50

112 ± 51

0.048*

HDL-C, mg/dl

35 ± 10

36 ± 11

35 ± 10

0.069

Triglyceride, mg/dl

130 ± 83

138 ± 102

123 ± 71

0.148

Total cholesterol, mg/dl

174 ± 52

173 ± 52

178 ± 51

0.301

Total protein, g/l

66 ± 8

65 ± 6

67 ± 9

0.001*

Albumin, g/l

41 ± 4

42 ± 4

42 ± 5

0.396

Haemoglobin, mg/dl

14.1 ± 2.3

13.8 ± 2.6

14.3 ± 2.4

0.001*

Haematocrit, %

41.8 ± 6.5

40.9 ± 7.0

42.6 ± 6.9

< 0.001*

Neutrophil, 10³ μl

6.3 ± 3.7

5.9 ± 3.2

6.7 ± 4.1

< 0.001*

Lymphocyte, 10³ μl

1.8 ± 0.8

1.8 ± 0.9

1.8 ± 0.8

0.746

Platelet, 10³ μl

258 ± 95

256 ± 95

259 ± 96

0.676

WBC, 10³/µl

9.3 ± 4.1

9.0 ± 3.7

9.8 ± 4.1

< 0.001*

MPV

8.2 ± 1.3

8.1 ± 1.0

8.3 ± 1.5

0.001*

CRP (mg/L)

14 ± 9

13 ± 8

15 ± 10

0.018*

Troponin (ng/L)

7657 ± 725

7269 ± 5664

8105 ± 9964

0.001*

LSR

33.8 ± 31.6

27.0 ± 26.1

42.4 ± 34.0

< 0.001*

HSR

15.9 ± 1.2

15.7 ± 1.1

16.3 ± 1.3

< 0.001*

MAPH

2.2 ± 0.9

2.0 ± 0.9

2.4 ± 0.9

< 0.001*